# Phenobarbital

## Phenobital inj 100mg/1mL

##### 臨採

| TAH Drug Code      | [IPHE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPHE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Seizures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Adult dosing: 1-2 mL QD, 15-7 years :0-1.5mL , 2-7 years :0.5-0.7mL, <2 years: 0.2-0.5mL, depending on the symptoms, it can be changed to 2~3 times a day.Can only be injected IM or SC, not IV.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity to phenobarbital, barbiturates or any component of the formulation; marked hepatic impairment; dyspnea or airway obstruction; porphyria (manifest and latent); intra-arterial administration, subcutaneous administration (not recommended); use in patients with a history of sedative/hypnotic addiction; nephritic patients (large doses).                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Cardiovascular: Bradycardia, hypotension, syncope, thrombophlebitis (IV) Central nervous system: Agitation, anxiety, ataxia, central nervous system stimulation, central nervous system depression, confusion, dizziness, drowsiness, hallucination, hangover effect, headache, impaired judgement, insomnia, lethargy, nervousness, nightmares Dermatologic: Exfoliative dermatitis, skin rash, Stevens-Johnson syndrome Gastrointestinal: Constipation, nausea, vomiting Genitourinary: Oliguria Hematologic & oncologic: Agranulocytosis, thrombocytopenia, megaloblastic anemia Local: Pain at injection site Neuromuscular & skeletal: Hyperkinesia, laryngospasm Respiratory: Apnea (especially with rapid IV use), hypoventilation, respiratory depression |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data – Potential Toxicity(Mother)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Phenobarbital 30mg

##### 

| TAH Drug Code      | [OPHE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OPHE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Generalised tonic-clonic seizures, Partial seizures, Sedation, Hypnotic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Adult: For anticonvulsant or ataxia: Oral: 100-200 mg HS or TID. For hypnotic: 100-200 mg HS. For CYP450 inducer: 30-60 mg TID. For sedative: 15-32 mg BID-TID. Child:For anticonvulsant or ataxia: Oral: 3-5 mg/kg HS or TID. For hypnotic: following doctor instruction. For CYP450 inducer,neonatel: 5-10 mg/kg. For CYP450 inducer, Child under 12 years : 1-4 mg/kg TID. For sedative: 2mg/kg or 60mg/BSA(m2) TID.                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Severe renal and hepatic disorders. Severe respiratory depression, dyspnoea or airway obstruction; porphyria. Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Bradycardia, hypotension, syncope; drowsiness, lethargy, CNS excitation or depression, impaired judgment, hangover effect, confusion, somnolence, agitation, hyperkinesia, ataxia, nervousness, headache, insomnia, nightmares, hallucinations, anxiety, dizziness; rash, exfoliative dermatitis; nausea, vomiting, constipation; agranulocytosis, thrombocytopenia, megaloblastic anaemia; pain at inj site, thrombophlebitis (IV); oliguria: laryngospasm, respiratory depression, apnoea (especially with rapid IV admin), hypoventilation. Potentially Fatal: Stevens-Johnson syndrome. Neurologic: Somnolence (1% to 3% ) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

